Intersect ENT (NASDAQ:XENT) Target Lowered by SVB Leerink LLC to $14.00

0
13

Intersect ENT stock has undergone multiple analysts rating changes in the recent past.  Intersect ENT stock Target Lowered by   SVB Leerink LLC on 6/29/2020. In a note to investors, the firm issued a new target price of $14.00. The analysts previously had $15.00 target price. SVB Leerink LLC’s price target would indicate a potential upside of 15.70% from the stock’s previous close.

Shares of Intersect ENT traded up $0.55 on Monday, reaching $12.65. 69312 shares of the stock traded hands, compared to its average volume of 361791. Shares of were trading at $12.65 on Monday. The firm’s 50 day moving average is $$11.89 and its 200 day moving average is $18.05.Intersect ENT  has a 12 month low of $12.05 and a 12 month high of $31.46. While on yearly highs and lows, Intersect ENT today has traded high as $12.66 and has touched $12.05 on the downward trend.

Intersect ENT Earnings and What to expect: 

Intersect ENT last posted its quarterly earnings results on May 11th, 2020. The medical equipment provider reported ($0.54) earnings per share for the quarter, missing the consensus estimate of ($0.44) by $0.10. The company earned $19.83 million during the quarter, compared to analysts’ expectations of $19.70 million. Intersect ENT has generated ($1.37) earnings per share over the last year. Intersect ENT has not formally confirmed its next earnings publication date, but the company’s estimated earnings date is Thursday, August 6th, 2020 based off prior year’s report dates.

Earnings for Intersect ENT are expected to grow in the coming year, from ($1.76) to ($1.28) per share. The P/E ratio of Intersect ENT is -7.76, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings. The P/E ratio of Intersect ENT is -7.76, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings. Intersect ENT has a P/B Ratio of 3.23. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

Latest Insiders Trading and Volume : 

  • Insider Ownership Percentage: 3.50%
  • On 3/17/2020 CEO Thomas A West Buy 19,035 at average share price of $8.95 which equates to $170,363.25 in money value.
  • On 3/16/2020 CFO Richard A. Meier Buy 10,000 at average price of  $12.55 with total value of : Not Data Available
  • On 11/5/2019 Insider Robert H. Binney, Jr. Sell 25,584 at average price of  $21.54 with total value of : $551,079.36
  • See More Analyst Rating at: RATING

Other Analyst’s rating for Intersect ENT

  • 6/23/2020 – Intersect ENT is now covered by analysts at Oppenheimer Holdings Inc.. They set a “market perform” rating on the stock.
  • 6/10/2020 – Intersect ENT had its “hold” rating re-affirmed by analysts at BTIG Research.
  • 5/23/2020 – Intersect ENT was downgraded by analysts at BidaskClub from a “hold” rating to a “sell” rating.
  • 5/12/2020 – Intersect ENT had its price target raised by analysts at SVB Leerink LLC from $13.00 to $15.00. They now have a “market perform” rating on the stock.
  • See More Analyst Rating at: RATING

Other rating updates by SVB Leerink LLC: 

  • 6/29/2020 – Nuance Communications is now covered by analysts at SVB Leerink LLC. They set an “outperform” rating and a $31.00 price target on the stock.
  • 6/26/2020 – Translate Bio had its price target raised by analysts at SVB Leerink LLC from $21.00 to $30.00. They now have an “outperform” rating on the stock.
  • 6/26/2020 – Acceleron Pharma had its price target raised by analysts at SVB Leerink LLC from $127.00 to $132.00. They now have an “outperform” rating on the stock.
  • 6/24/2020 – Affimed had its price target raised by analysts at SVB Leerink LLC from $7.00 to $8.00. They now have an “outperform” rating on the stock.
  • See More Analyst Rating at: RATING

Intersect ENT (NASDAQ:XENT) Moving Average Technical Analysis

5 day Moving Average is $$12.36 And 5 day price change is $0.04 (0.33%)  with average volume for 5 day average is 389,300. While technical analysis for average 20 days shows significant difference, 20 day moving average is  $12.40 and 20 day price change is $0.95 (8.52%) and average 20 day moving volume is 367,885. 50 day moving average is $11.89  and 50 day price change is $3.00 ( 32.97%)  and with average volume for 50 days is : 454,774. 200 day moving average is $18.05  and 200 day price change is -$5.57 (-31.52%)  and with average volume for 200 days is : 609,937.

See More Analyst Rating at: RATING